Kilitch Drugs (India) Limited

Kilitch Drugs (India) Limited

Share · INE729D01010 (XBOM)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Kilitch Drugs (India) Limited
No Price
Closing Price XBOM 29.04.2026: 152,75 INR
29.04.2026 09:59
Current Prices from Kilitch Drugs (India) Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
KILITCH.NS
INR
29.04.2026 09:59
154,11 INR
0,33 INR
+0,21 %
XBOM: MSE
MSE
KILITCH.BO
INR
29.04.2026 09:46
152,75 INR
-1,03 INR
-0,67 %
Share Float & Liquidity
Free Float 21,19 %
Shares Float 7,41 M
Shares Outstanding 34,96 M
Company Profile for Kilitch Drugs (India) Limited Share
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of liquid ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, capsules, dry syrup, gripe water, and oral powder and liquid in the antibiotic, anti-diabetics, cardiovascular, and other areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, ROIVIT, and PH-7; and various nutritional products, such as CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, lotions, liquids, creams, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.

Company Data

Name Kilitch Drugs (India) Limited
Company Kilitch Drugs (India) Limited
Website https://www.kilitch.com
Primary Exchange XBOM MSE
ISIN INE729D01010
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mukund Prataprai Mehta
Market Capitalization 5 Mrd.
Country India
Currency INR
Employees 0,2 T
Address 37/39, Ujagar Industrial Estate, 400088 Mumbai
IPO Date 2002-03-05
Dividends from 'Kilitch Drugs (India) Limited'
Ex-Date Dividend per Share
20.09.2019 0,50 INR
18.09.2018 0,50 INR
24.09.2012 30,00 INR
24.09.2012 30,00 INR
18.08.2011 1,00 INR
18.08.2011 1,00 INR
14.10.2010 1,00 INR
10.09.2009 1,00 INR
10.09.2008 1,00 INR
15.11.2007 1,00 INR

Stock Splits

Date Split
24.03.2026 2:1
15.07.2025 1021:1000

Ticker Symbols

Name Symbol
MSE KILITCH.BO
NSE KILITCH.NS
More Shares
Investors who hold Kilitch Drugs (India) Limited also have the following shares in their portfolio:
HSBC BANK PLC MAW LKD ORD A SHS TONGWEI 23/11/22
HSBC BANK PLC MAW LKD ORD A SHS TONGWEI 23/11/22 Bond
MILA RESOURCES PLC - ORD GBP0.01
MILA RESOURCES PLC - ORD GBP0.01 Share